Merck & Co Inc
NYSE: MRK
$100.86
+$1.14 (+1.1%)
Real Time Data Delayed 15 Min.
MRK Articles
In a year that saw the Dow add more than 24%, 5 stocks posted share price declines ranging from 1% to 45%. How did that happen?
Published:
Last Updated:
UnitedHealth, American Express, Merck, and IBM led the DJIA to a positive finish on Thursday.
Published:
Last Updated:
The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.
Published:
Last Updated:
One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the Dow.
Published:
Last Updated:
With the passage of tax reform looking almost certain, and with companies continuing to prove that all-time highs in the market will not hurt spending cash on share buybacks, the continuation of...
Published:
Last Updated:
Caterpillar, UnitedHealth, Merck, and Verizon were among the largest losers among DJIA stocks on Thursday.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
Apple, Disney, Merck, and Pfizer were the leading gainers among the Dow 30 stocks on Monday. Bitcoin settled up 23% after its first trading session.
Published:
Last Updated:
The question for investors is pretty simple: 2017 was great, but what do they do for an encore in 2018?
Published:
Last Updated:
Some down and out stocks don't always stay down, and sometimes great turnarounds and recoveries can create huge victories for opportunistic and visionary investors.
Published:
Last Updated:
Microsoft and Vise were Wednesday's big DJIA gainers while Merck and Disney dipped the most.
Published:
Last Updated:
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
Published:
Last Updated:
One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be “deep value” plays at Merrill Lynch.
Published:
Merck, Omega Health, Cardinal Health, and Curis all posted new 52-week lows Monday.
Published:
Last Updated:
Intel, Merck, McDonald's, and Exxon Mobil weighed on the DJIA Friday.
Published:
Last Updated: